Inventor · disambiguated record
Robert V. Market
Also filed as: MARKET ROBERT · MARKET ROBERT V
19 granted patents·5 pending applications·208 citations·filing 1991–2022
94Inventor score
Files withTEXAS HEART INST6BIEDIGER RONALD J4ENCYSIVE PHARMACEUTICALS INC4TEXAS BIOTECHNOLOGY CORP3ANDERSON ERIC C2
Top patents by PatentIndex Score
24 records- 0186US10246451B2Propionic acid derivatives and methods of use thereofBIEDIGER RONALD J·Filed 2017·Granted Apr 2, 2019·7 cites·14 claims
- 0285US7579340B2Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsPFIZER·Filed 2007·Granted Aug 25, 2009·4 cites·6 claims
- 0385US6723711B2Propanoic acid derivatives that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Apr 20, 2004·35 cites·13 claims
- 0482US10494367B2Propionic acid derivatives and methods of use thereofBIEDIGER RONALD J·Filed 2019·Granted Dec 3, 2019·4 cites·19 claims
- 0581US6194448B1N, N-disubstituted amides that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Feb 27, 2001·42 cites·17 claims
- 0680US6972296B2Carboxylic acid derivatives that inhibit the binding of integrins to their receptorsENCYSIVE PHARMACEUTICALS INC·Filed 2001·Granted Dec 6, 2005·14 cites·8 claims
- 0778US9512109B2Agonists that enhance binding of integrin-expressing cells to integrin receptorsBIEDIGER RONALD J·Filed 2011·Granted Dec 6, 2016·4 cites·1 claims
- 0874US7288538B2Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2004·Granted Oct 30, 2007·5 cites·7 claims
- 0974US6096773ACompounds that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP INC·Filed 1999·Granted Aug 1, 2000·33 cites·10 claims
- 1073US5190640ATreatment of oils using aminocarbinolsBAKER HUGHES INC·Filed 1991·Granted Mar 2, 1993·29 cites·19 claims
- 1171US7812038B2Carboxylic acid derivatives that inhibit the binding of integrins to their receptorsENCYSIVE PHARMACEUTICALS INC·Filed 2005·Granted Oct 12, 2010·1 cites·7 claims
- 1268US7319111B2Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2004·Granted Jan 15, 2008·4 cites·4 claims
- 1366US6262084B1Compounds that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 17, 2001·18 cites·10 claims
- 1463US2019210992A1Agonists that enhance binding of integrin-expressing cells to integrin receptorsTEXAS HEART INST·Filed 2019·Application pending·0 cites
- 1561US8178699B2Modulators of CCR9 receptor and methods of use thereofANDERSON ERIC C·Filed 2008·Granted May 15, 2012·0 cites·2 claims
- 1659US2025099423A1Piperazine-based agonists of lfa-1 and vla-4TEXAS HEART INST·Filed 2022·Application pending·0 cites
- 1757US10287264B2Agonists that enhance binding of integrin-expressing cells to integrin receptorsTEXAS HEART INST·Filed 2016·Granted May 14, 2019·0 cites·8 claims
- 1857US2024360113A1Aminoaryl-integrin agonists compoundsTEXAS HEART INST·Filed 2022·Application pending·0 cites
- 1956US10071980B2Agonists that enhanced binding of integrin-expressing cells to integrin receptorsTEXAS HEART INST·Filed 2015·Granted Sep 11, 2018·0 cites·3 claims
- 2053US2021393811A1Imaging Agents and Methods of UseTEXAS HEART INST·Filed 2019·Application pending·0 cites
- 2149US2011028469A1Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 ReceptorANDERSON ERIC C·Filed 2008·Application pending·0 cites
- 2242US5344555ATreatment of oils using reaction products of epoxides and tertiary aminesBAKER HUGHES INC·Filed 1993·Granted Sep 6, 1994·8 cites·23 claims
- 2340US11312685B2Targeting nanoparticlesTEXAS CHILDRENS HOSPTIAL·Filed 2018·Granted Apr 26, 2022·0 cites·56 claims
- 2439US10875875B2Propionic acid derivatives and methods of use thereofBIEDIGER RONALD J·Filed 2017·Granted Dec 29, 2020·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Robert V. Market files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →